Amanote Research
Register
Sign In
Factors Associated With Quality of Life and Functional Disability Among Rheumatoid Arthritis Patients Treated With Disease-Modifying Anti-Rheumatic Drugs for at Least Six-Months
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.03.1098
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2016
Authors
S. Bae
H. Koh
Y. Kim
Publisher
Elsevier BV
Related search
Safety, Cost and Effectiveness Issues With Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients With Rheumatoid Arthritis?
Neurotherapeutics
Neurology
Pharmacology
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
THU0094 Factors Associated With Radiographic Remission (RR) in Patients With Rheumatoid Arthritis (RA) While Non-Biologicaldisease Modifying Anti-Rheumatic Drugs (DMARDS) Using
OP0281-HPR Preferences of Patients With Rheumatoid Arthritis Regarding Disease Modifying Anti-Rheumatic Drugs: A Discrete Choice Experiment
Sleep Quality and Functional Disability in Patients With Rheumatoid Arthritis
Journal of Clinical Sleep Medicine
Pulmonary
Neurology
Respiratory Medicine
Predictors and Effective Factors on Quality of Life Among Iranian Patients With Rheumatoid Arthritis
Materia Socio Medica
Anti-Citrullinated Cyclic Peptide Antibody and Functional Disability Are Associated With Poor Sleep Quality in Rheumatoid Arthritis
Archives of Rheumatology
Rheumatology
Effect of Disease-Modifying Anti-Rheumatic Drugs on Bone Structure and Strength in Psoriatic Arthritis Patients
Arthritis Research & Therapy
